Open AccessTreatment of Hospital-Acquired Infections in Patients with Cirrhosis – New Challenges
Author(s) -
Dadasaheb G Maindad,
Sadasivam Suresh,
Suchitra Shenoy M,
Sandeep Gopal,
Bailuru Vishwanath Tantry
Publication year - 2022
Publication title -
infection and drug resistance
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.033
H-Index - 39
ISSN - 1178-6973
DOI - 10.2147/idr.s283723
Subject(s) - medicine , antibiotics , tigecycline , meropenem , cirrhosis , antibiotic resistance , drug resistance , cephalosporin , vancomycin , staphylococcus aureus , microbiology and biotechnology , bacteria , biology , genetics
Hospital acquired infections (HAI) in the cirrhotic patients contribute to hepatic decompensation. With emergence of bacterial drug resistance, designing the treatment protocol of HA infection has become the foremost challenge.